Navigation Links
UK supplier of graphenes announces exclusive sales agency agreement with leading USA distributor
Date:6/11/2012

Haydale Limited ("Haydale"), and Cheap Tubes Inc ("CTi"), today announce that they have reached agreement for CTi to act as the exclusive agent for the supply of the Haydale HDPlas nano products in the United States, Canada, and Mexico.

Haydale's unique patented Split Plasma based technology enables the scaleable, environmentally friendly, exfoliation and purification of single and few layer friable Graphenes containing powders known as Graphene Nano Platelets ("GNPs") from mined graphite crystals. Under the agreement Haydale will supply its GNPs and Split Plasma treated Carbon Nano Tubes ("CNTs") which are now available from CTi under the brand HDPlas.

Critically, organisations can now use the HDPlas product range for collaborative product prototyping and analysis. Haydale offers expertise in running pilot trials to evaluate the effect their friable GNPs have on the clients' materials and products and, crucially, assessing their suitability for large scale production. The key to subsequent take up by the client is the knowledge that there is a reliable, quality product available in commercial quantities.

As part of the agreement CTi will be exhibiting the HDPlas products and offering samples to attendees at the TechConnect World NSTI conference in Santa Clara on June 18- 21st.

"TechConnect has always been a fantastic trade show for us to exhibit our products at; please visit us at booth #506 to enquire about our HDPlas products" says CTI's President Mike Foley.

Haydale's Commercial Director Ray Gibbs said:

"The market is looking for ways of using the new wonder material Graphene and we believe that we have the process that can now supply both the research and commercial quantities required. Haydale is now able to supply HDPlas from stock in grams or kilos and is ready and able to take orders for tonnes to agreed delivery dates. CTi offers us a real means of quickly getting our quality products initially i
'/>"/>

Contact: Trevor Phillips
trevor.phillips@hermesfinancialpr.co.uk
44-788-915-3628
Hermes Financial Public Relations
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
2. TOKU-E Announces Safer and Faster Dissolving, Dust-Free Grade Sodium Dodecyl Sulfate (SDS) for Electrophoresis and Manufacturing Applications
3. Sequenom Announces Participation at the Jefferies Global Healthcare Conference
4. Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
5. EPSRC announces first recipients of Fellowships in Manufacturing
6. Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
7. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
8. Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis
9. Diversionary Therapy Announces First Sale of ditto™ dental
10. IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research
11. Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UK supplier of graphenes announces exclusive sales agency agreement with leading USA distributor
(Date:11/24/2014)... N.J. , Nov. 24, 2014  IGI Laboratories, ... based specialty generic pharmaceutical company, today announced ... (ANDA) to the U.S. Food and Drug Administration (FDA), ... in 2014 to seven, with eighteen submissions now pending ... , President and CEO of the Company, commented, "Our ...
(Date:11/24/2014)... Belgium , Nov. 24, 2014 VolitionRx ... developing diagnostic tests for cancer and other conditions, today announced ... presented at the Science for Business BioWin Day 2014, being ... . The data come from VolitionRx,s lung cancer pilot study, ... of the Centre Hospitalier Universitaire (CHU) de Liege in ...
(Date:11/24/2014)... Washington, USA (PRWEB) November 23, 2014 One ... dynamic field of optics and photonics is now available to ... or very low cost. SPIE, the international society for ... access to the complete SPIE Digital Library available ... subsidized price. , “Light-based technologies are integral to all areas ...
(Date:11/24/2014)... Massachusetts (PRWEB) November 24, 2014 ... Panels ” from METTLER TOLEDO demonstrates how to ... , Power analytics and sample panel design can ... cycle chemistry and protect against corrosion and deposition. ... up a significant amount of panel space. Additionally, ...
Breaking Biology Technology:IGI Laboratories, Inc. Announces ANDA Submission 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 4VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 5VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 6SPIE Digital Library Now Available to High Schools, Two-Year Colleges at No or Low Cost 2New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2
... to high quality, practice management and reimbursement content ... available through web-based delivery platform, DALLAS-FORT ... develops products and services to help accelerate,advancements in the ... in web-based delivery of healthcare,information, have joined forces to ...
... Aton Pharma, Inc., a,global specialty pharmaceutical ... an expanded, comprehensive distribution program that ... resources, for the,dry eye medication Lacrisert(R) ... unique preservative-free, once-daily*, sustained,release prescription insert ...
... the active elements in the next generation of electronic ... nanotubes within device architectures. Most of the approaches for ... applicable to discrete devices and are not readily scalable ... nanotube-based chips. Now, this seemingly intractable problem has been ...
Cached Biology Technology:Oncology Metrics and E-Expert Reimbursement Partners Announce Joint Marketing and Product Development Agreement 2Oncology Metrics and E-Expert Reimbursement Partners Announce Joint Marketing and Product Development Agreement 3Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye 2Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye 3Nanotubes go with the flow 2
(Date:11/6/2014)... metastasis, yet progress in preventing and treating migratory ... particularly challenging to design drugs that work against ... biology at Harvard Medical School. , "Unfortunately, ... metastasized." , Gujral and colleagues have now identified ... understand how metastasis begins. Their findings may also ...
(Date:11/6/2014)... 6, 2014 - Insilico Medicine, Inc, a Baltimore-based ... age related diseases announced a research collaboration with ... Champions Oncology, Inc (OTC: CSBR). , "There are ... medicine, but Champions Oncology,s TumorGraft technology is unique ... chemotherapy regimen experimentally generating vast amounts of valuable ...
(Date:11/5/2014)... career to understanding the Earth,s climate and communicating ... deputy director and regional climatologist for the Western ... Redmond has more than three decades of experience ... data to the general public. , At its ... December 15-19, 2014 the American Geophysical Union (AGU) ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2
... Duchenne muscular dystrophy (DMD) face a future of rapidly weakening ... failure before their 30th birthday. While researchers are hopeful that ... have targeted the heart of the problem as much as ... grant he received from the National Institutes of Health will ...
... of toxicity in the four hemophilia B patients enrolled to ... development at St. Jude Children,s Research Hospital and UCL (University ... This trial was designed primarily as a safety test, with ... little detectable Factor IX. The Factor IX protein helps the ...
... LLC, the image analysis and pattern recognition technology ... was awarded best performance for forensic signature verification ... Handwriting Recognition (ICFHR2010) in Kolkata, India, held November ... participants representing a total of 10 offline signature ...
Cached Biology News:New NIH grant helps MU scientist get to the heart of muscular dystrophy 2Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B 2Parascript SignatureXpert Wins Forensic Signature Verification Competition 2
Mouse monoclonal antibody raised against a full length recombinant CSNK2A2. NCBI Entrez Gene ID = CSNK2A2...
... & SSM4, Small space saving design - ideal ... of two models: , - 3D gyratory action ... , Digital speed control and built-in timer , Optional ... rockers are ideal where gentle mixing is required, either ...
... provides optimized reagents and protocols for the ... by insertion of group II introns. The ... II introns and utilizes a simple PCR ... intron for specific insertion into the host ...
...
Biology Products: